At the Galaxy Unpacked 2026 event held in London, Samsung made a number of key announcements, with the unveiling of new smartphones and smartwatches taking center stage. Amidst the main reveals, the company quietly shared some exciting news about the Galaxy Ring, set to introduce a major new health-tracking feature. Starting later this year, the Galaxy Ring will offer sleep apnea risk monitoring with FDA approval, marking a significant step in the wearable tech market.
FDA approval gives Galaxy Ring a unique advantage
According to Samsung, the Galaxy Ring will be the first smart ring to receive FDA clearance for sleep apnea risk monitoring. While other smart rings, such as the Oura and RingConn, already offer features that track SpO2 levels and monitor breathing patterns, they do not have the same level of formal regulatory approval. The FDA clearance adds a layer of validation and reliability, setting the Galaxy Ring apart from competitors in the wearable health device space.
What the new feature can and cannot do
It's important to clarify that the Galaxy Ring’s new feature will not diagnose sleep apnea. Instead, it will monitor key indicators during the night, such as changes in blood oxygen levels and irregular breathing patterns. If the device detects possible signs of risk, it will alert the user to consult a healthcare professional for a proper diagnosis. The goal of the feature is to help users identify potential issues earlier and seek medical advice.
When to expect the new functionality
Samsung has shared its rollout timeline for the new sleep apnea risk monitoring feature. The Galaxy Watch series will be the first to receive the FDA-cleared update during the summer of 2026. Later in the fall, the Galaxy Ring will also gain access to the same functionality. Samsung views this as a major milestone in wearable health technology, demonstrating how smart accessories can increasingly assist with proactive health management.